Adis Journals
Browse

Real-World Safety Outcomes of Intravitreal Ranibizumab Biosimilar (Razumab) Therapy for Chorioretinal Diseases

Download (136.78 kB)
Version 2 2021-04-19, 09:47
Version 1 2021-04-13, 14:59
media
posted on 2021-04-19, 09:47 authored by Adis Journals on behalf of, Debdulal Chakraborty, Michael W. Stewart, Jay U. Sheth, Tushar K. Sinha, Subhendu Boral, Arnab Das, Soumen Mondal, Angshuman Mukherjee
<p><strong>Article full text</strong></p> <p> </p> <p><br></p> <p> </p> <p>The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). </p> <p>© The authors, CC-BY-NC 2021.</p>

History

Usage metrics

    Ophthalmology and Therapy

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC